Back to Trades
McCulloch Kevin
See RemarksCIK 0002031695
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
McCulloch Kevin, See Remarks, has filed 10 SEC reports (2025–2026), all concentrated in Xeris Biopharma Holdings, Inc. (XERS), totaling $4.3M in disclosed volume. Weighing $0 bought versus $1.1M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Sep 1 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Sell | $127.3K |
| Aug 21 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Tax withheld | $177.1K |
| Aug 4 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Sell | $120.2K |
| Jul 2 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Sell | $722.5K |
| Mar 16 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Exercise | $400.0K |
| Feb 2 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Grant | $2.6M |
| Jan 9 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Sell | $120.0K |
| Oct 3 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Tax withheld | $6.1K |
| Sep 15 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Other | $0 |
| Aug 4 | XERS Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | Tax withheld | $78.8K |
10 filings